Oxygene Medicinal Liquide S.O.L. (Oxygen)

Oxygene Medicinal Liquide S.O.L. is used in respiratory support and related clinical pathways.

• Acute hypoxemia: improves arterial oxygen saturation during acute respiratory distress.
• Chronic obstructive pulmonary disease (COPD): assists long‑term oxygen therapy to maintain adequate tissue oxygenation.
• Post‑operative recovery: provides supplemental oxygen to aid postoperative breathing and prevent hypoxia.

• The liquid oxygen is vaporised and delivered to the lungs, where it diffuses across the alveolar membrane into the bloodstream, raising the partial pressure of oxygen in arterial blood. This enhances cellular respiration and supports metabolic processes in tissues that are experiencing oxygen deficiency.

Oxygene Medicinal Liquide S.O.L. may cause adverse reactions related to the inhaled gas and its delivery system.

Common Side Effects

• Cough or throat irritation: mild discomfort during inhalation.
• Nasal dryness: reduced moisture in nasal passages.
• Headache: transient headache associated with changes in oxygen levels.

Serious or Rare Side Effects

• Pulmonary oxygen toxicity: risk of lung injury with prolonged high‑concentration exposure.
• Fire hazard: oxygen‑rich environment increases flammability of surrounding materials.
• Hypoxemia rebound: sudden reduction in oxygen after abrupt discontinuation.
• Barotrauma: pressure‑related injury if delivery system is mis‑used.

When using Oxygene Medicinal Liquide S.O.L., clinicians should observe standard safety measures for medical gases.

• Patient assessment: verify indication and required oxygen flow rate before administration.
• Monitoring: continuously observe oxygen saturation and respiratory status.
• Equipment compatibility: ensure delivery devices are rated for liquid oxygen use.
• Fire safety: keep away from open flames, sparks, and smoking materials.
• Storage: keep at ambient temperature: store in original container, protect from direct sunlight and extreme temperatures.

Oxygene Medicinal Liquide S.O.L. has limited pharmacologic interactions, but the presence of high‑concentration oxygen can affect the safety profile of certain therapies.

Major Interactions (Avoid)

• Nitrogen‑dioxide generators: avoid concurrent use as they can create toxic nitrogen oxides.
• Flammable anesthetic agents: increased fire risk when combined with high‑flow oxygen.

Moderate Interactions (Monitor Closely)

• Parenteral vasodilators: may enhance systemic vasodilation when oxygen improves tissue oxygenation.
• Certain chemotherapeutic agents (e.g., bleomycin): oxygen may potent 
•     ");